CITIUS ONCOLOGY, INC. (CTOR)
Nasdaq: CTOR · CIK 0001851484 · United States
Every official CITIUS ONCOLOGY, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CTOR filings
CITIUS ONCOLOGY, INC. documents
- CITIUS ONCOLOGY, INC. 10-K 2026CTOR 10-K 2026: annual report for fiscal 2026
- CITIUS ONCOLOGY, INC. 10-K 2025CTOR 10-K 2025: annual report for fiscal 2025
- CITIUS ONCOLOGY, INC. 10-K 2024CTOR 10-K 2024: annual report for fiscal 2024
- CITIUS ONCOLOGY, INC. 10-K 2023CTOR 10-K 2023: annual report for fiscal 2023
- CITIUS ONCOLOGY, INC. 10-K 2022CTOR 10-K 2022: annual report for fiscal 2022
- CITIUS ONCOLOGY, INC. 10-Q 2026CTOR 10-Q 2026: quarterly report for fiscal 2026
- CITIUS ONCOLOGY, INC. 10-Q 2025CTOR 10-Q 2025: quarterly report for fiscal 2025
- CITIUS ONCOLOGY, INC. 10-Q 2024CTOR 10-Q 2024: quarterly report for fiscal 2024
- CITIUS ONCOLOGY, INC. 10-Q 2023CTOR 10-Q 2023: quarterly report for fiscal 2023
- CITIUS ONCOLOGY, INC. 10-Q 2022CTOR 10-Q 2022: quarterly report for fiscal 2022
- CITIUS ONCOLOGY, INC. 8-K 2026CTOR 8-K 2026: current report for fiscal 2026
- CITIUS ONCOLOGY, INC. 8-K 2025CTOR 8-K 2025: current report for fiscal 2025
- CITIUS ONCOLOGY, INC. 8-K 2024CTOR 8-K 2024: current report for fiscal 2024
- CITIUS ONCOLOGY, INC. 8-K 2023CTOR 8-K 2023: current report for fiscal 2023
- CITIUS ONCOLOGY, INC. 8-K 2022CTOR 8-K 2022: current report for fiscal 2022
- CITIUS ONCOLOGY, INC. DEF 14A 2026CTOR DEF 14A 2026: proxy statement for fiscal 2026
- CITIUS ONCOLOGY, INC. DEF 14A 2025CTOR DEF 14A 2025: proxy statement for fiscal 2025
- CITIUS ONCOLOGY, INC. DEF 14A 2024CTOR DEF 14A 2024: proxy statement for fiscal 2024
- CITIUS ONCOLOGY, INC. DEF 14A 2023CTOR DEF 14A 2023: proxy statement for fiscal 2023
- CITIUS ONCOLOGY, INC. DEF 14A 2022CTOR DEF 14A 2022: proxy statement for fiscal 2022
- CITIUS ONCOLOGY, INC. Form 4 2026CTOR Form 4 2026: insider trading filing for fiscal 2026
- CITIUS ONCOLOGY, INC. Form 4 2025CTOR Form 4 2025: insider trading filing for fiscal 2025
- CITIUS ONCOLOGY, INC. Form 4 2024CTOR Form 4 2024: insider trading filing for fiscal 2024
- CITIUS ONCOLOGY, INC. Form 4 2023CTOR Form 4 2023: insider trading filing for fiscal 2023
- CITIUS ONCOLOGY, INC. Form 4 2022CTOR Form 4 2022: insider trading filing for fiscal 2022
- CITIUS ONCOLOGY, INC. S-1 2026CTOR S-1 2026: registration statement for fiscal 2026
- CITIUS ONCOLOGY, INC. S-1 2025CTOR S-1 2025: registration statement for fiscal 2025
- CITIUS ONCOLOGY, INC. S-1 2024CTOR S-1 2024: registration statement for fiscal 2024
- CITIUS ONCOLOGY, INC. S-1 2023CTOR S-1 2023: registration statement for fiscal 2023
- CITIUS ONCOLOGY, INC. S-1 2022CTOR S-1 2022: registration statement for fiscal 2022
- CITIUS ONCOLOGY, INC. 13F 2026CTOR 13F 2026: institutional holdings for fiscal 2026
- CITIUS ONCOLOGY, INC. 13F 2025CTOR 13F 2025: institutional holdings for fiscal 2025
- CITIUS ONCOLOGY, INC. 13F 2024CTOR 13F 2024: institutional holdings for fiscal 2024
- CITIUS ONCOLOGY, INC. 13F 2023CTOR 13F 2023: institutional holdings for fiscal 2023
- CITIUS ONCOLOGY, INC. 13F 2022CTOR 13F 2022: institutional holdings for fiscal 2022
More companies